BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10478259)

  • 1. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.
    Loyer EM; Chin H; DuBrow RA; David CL; Eftekhari F; Charnsangavej C
    Radiology; 1999 Sep; 212(3):866-75. PubMed ID: 10478259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
    Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
    Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver tumor characterization--review of the literature.
    Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(1):18-24. PubMed ID: 16365567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
    Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
    Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma.
    Tillich M; Mischinger HJ; Preisegger KH; Rabl H; Szolar DH
    AJR Am J Roentgenol; 1998 Sep; 171(3):651-8. PubMed ID: 9725291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced CT of intrahepatic and hilar cholangiocarcinoma: delay time for optimal imaging.
    Keogan MT; Seabourn JT; Paulson EK; McDermott VG; Delong DM; Nelson RC
    AJR Am J Roentgenol; 1997 Dec; 169(6):1493-9. PubMed ID: 9393152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings.
    Kim TK; Choi BI; Han JK; Jang HJ; Cho SG; Han MC
    Radiology; 1997 Aug; 204(2):539-43. PubMed ID: 9240550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
    Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
    Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features.
    Fukukura Y; Taguchi J; Nakashima O; Wada Y; Kojiro M
    J Comput Assist Tomogr; 1997; 21(1):52-8. PubMed ID: 9022770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.
    Vilana R; Forner A; Bianchi L; García-Criado A; Rimola J; de Lope CR; Reig M; Ayuso C; Brú C; Bruix J
    Hepatology; 2010 Jun; 51(6):2020-9. PubMed ID: 20512990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(2):173-81. PubMed ID: 16628028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines.
    Dietrich CF; Cui XW; Boozari B; Hocke M; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S57-66. PubMed ID: 22723030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
    Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
    PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.